Human Basophil Releasability. VIII. Increased Basophil Releasability in Patients with Scleroderma

Open Access
Publisher Website
Google Scholar
Abstract
We evaluated basophil releasability in 16 female patients with scleroderma (systemic sclerosis) and in 16 normal age- and sex-matched donors. Basophils from patients with scleroderma released significantly more histamine „spontaneously”︁ than did those from normal donors (12.9 ± 2.1% versus 4.5 ± 0.7%; P < 0.0005). Basophil reactivity (maximal percentage histamine release) to anti-IgE was higher in patients with scleroderma than in controls (57.0 ± 7.5% versus 35.4 ± 7.8%; P < 0.05). Basophil sensitivity (the concentration of anti-IgE that causes 40% of maximal percentage histamine release) to anti-IgE in scleroderma patients was similar to that found in controls (4.6 ± 2.8 × 10−2 μg/ml versus 2.3 ± 1.0 × 10−1 μg/ml; P not significant). Scleroderma patients also showed enhanced releasability compared with that of the controls when challenged in vitro with interleukin-3 (8.3 ± 1.7% versus 3.2 ± 0.6% P < 0.01). Releasability induced by the formylcontaining tripeptide, f-met peptide, was significantly higher in the scleroderma patients than in the controls at the 2 lower concentrations used. No differences in basophil reactivity and sensitivity to f-met peptide and calcium ionophore A23187 were found between patients and normal donors. These results show that spontaneous basophil releasability and releasability in response to IgE cross-linking and activation of interleukin-3 receptors are increased in patients with scleroderma.